Healthcare - Biotechnology - NASDAQ - US
$ 26.5
-9.99 %
$ 172 M
Market Cap
-1.44
P/E
INCOME STATEMENT
0
REVENUE
-159 M
OPERATING INCOME
-156 M
NET INCOME
EFFICIENCY
Earnings Waterfall
Instil Bio, Inc.
| Revenue | 0 |
| Cost Of Revenue | 4.76 M |
| Gross Profit | -4.76 M |
| Operating Expenses | 85.8 M |
| Operating Income | -159 M |
| Other Expenses | -3.08 M |
| Net Income | -156 M |
Income Statement
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | |
|---|---|---|---|---|---|
| REVENUE | |||||
| Revenue | 0 | 0 | 0 | 0.1 | 0 |
| GROSS PROFIT | |||||
| Cost Of Revenue | 4.8 | 6.0 | 2.8 | 0 | 20 K |
| Gross Profit | (4.8) | (6.0) | (2.8) | 0.1 | 20 K |
| OPERATING INCOME | |||||
| Operating Expenses | 85.8 | 203.3 | 155.6 | 33.8 | 6.6 |
| Selling, General and Administrative Expenses | 47.6 | 62.2 | 48.3 | 14.4 | 2.6 |
| Research and Development Expenses | 43.0 | 141.1 | 107.3 | 19.4 | 4.0 |
| Operating Income | (159.2) | (226.5) | (155.6) | (33.6) | (6.6) |
| PRE-TAX INCOME | |||||
| Interest Income Expense | 5.2 | 1.9 | 0 | 0 | 0 |
| Total Other Income | 3.1 | 1.2 | (1.2) | (3.9) | 63 K |
| Pre-Tax Income | (156.1) | (225.2) | (156.8) | (37.6) | (6.5) |
| NET INCOME | |||||
| Tax Provision | 0 | (2.1) | 39 K | 0.2 | 68 K |
| Net Income | (156.1) | (223.2) | (156.8) | (37.7) | (6.5) |
| EPS | 24 | 34.5 | 24.3 | 5.89 | 1.01 |